Temporary cortical blindness as a complication of posterior angiography is reported in 11 patients and compared with 30 similar cases previously reported. Theoretical considerations of etiology implicate transitory alterations of the blood-brain barrier in the striate cortex.
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cortical blindness blood-brain barrier FTER three patients developed temporary cortical blindness following angiographic study of the vertebrobasilar system, we studied the records of eight additional patients who had experienced this complication at four area hospitals. In each instance, the blind patient was found to have normal pupillary responses to light and no funduscopic abnormality. Table 1 summarizes the 11 cases. The operative technique used was fairly standard: a No. 5-7 French polyethylene catheter was introduced through the femoral artery into the aortic arch or the orifice of the vertebral or carotid artery. The only exception was in Case 6, in which a right retrograde percutaneous brachial injection was made with a No. 17 Grino needle. All of the patients received at least one injection that filled the posterior circulation, either directly through the vertebral artery itself or secondarily from the aortic arch or brachial artery. In the catheter cases, 3 to 8 cc/sec of contrast medium were delivered by a standard power injector; 30 cc/sec were delivered by the brachial route. The patients were given local anesthesia, usually lidocaine, sometimes supplemented with intravenous diazepam.
Analysis of Cases

Discussion
In previous series, about 1% of the patients undergoing angiography with catheter injection of methylglucamine compounds became temporarily blind. 7,12,14 All ultimately regained their preangiographic visual states; one patient reported by Kaplan and Walker, 9 however, was left with a residual visual agnosia after angiography with Diodrast. These 30 cases cited in the literature are summarized in Table 2 . In our series we cannot arrive at a reliable incidence of temporary blindness as a percentage of total studies performed.
No satisfactory explanation for the temporary visual loss has been given. Walsh and Hoyt 13 emphasized that "cortical blindness" (selective involvement of the occipital visual cortex) should be differentiated from "cerebral blindness" (bilateral homonymous hemianopsia resulting from a more extensive anteriorly placed lesion). They believed that the most important factors associated with cortical blindness were a hypotensive episode during angiography, the presence of hypertensive vascular disease, and the amount and concentration of the contrast solution during a single injection. Sudden hypotension did develop in one of our cases (Case 1), requiring vasopressors for several hours; none of our 11 patients had hypertension. Walsh and Hoyt may have been influenced by the previous report of Silverman, et al., 11 who found that four of their eight patients had high blood pressure. Although Silverman, et al., 11 used the term "cerebral blindness," in reality they described cortical blindness and identified the order in which vision was recovered: light, motion, form, color, central and, finally, peripheral vision. In our patients, the findings were similar, including the complaint of visual hallucinations (Cases 7 and 8) and denial of blindness (Case 11 ).
The degree that the blood-brain barrier is altered by iodinated contrast media injected intraarterially has been shown to be directly proportional to the amount, concentration, and length of time it is in contact with the capillary endothelium. 4 The concentration in our cases was usually ~60%; in three instances both 60% and 76% were used. In many previous cases (Table 2 ) a 35% solution was used, but these were sodium salts and consequently the two groups are not comparable. Double blind clinical studies 5 have provided convincing evidence that methylglucamine salts are superior to sodium salts of iodinated compounds because of less toxicity and fewer complica- 9 9 immediate to ? 4-5 hrs ?
') 9 9 9 tions. In cerebral angiography, however, there is no convincing proof that methylglucamine iothalamate (Conray) is a safer medium than methylglucamine diatrizoate (Renografin or Hypaque 60) ; no superiority was evident in our 11 cases since the complications were about evenly divided between the two media. Obviously, the greater the number of injections, the greater the chance for complications. Yet Aasved's 1 patient received only 7 cc, and our patient (Case 1 1) received only 8 cc in a single injection, suggesting that multiple injections are not necessary to produce blindness. Slowed circulation time, resulting in prolonged contact of the medium with the endotheliurn, could also be a cause; this was noted only once (Case 9) when the marked increase in intracranial pressure secondary to a cerebellar tumor presumably was interfering with the cerebral blood flow. No information is available on this point in the cases listed in Table 2 .
Another explanation might be that injection of contrast medium produces a temporary and partial disruption of the blood-brain barrier so that a transient edema occurs selectively in the striate cortex, severe enough to cause blindness; with reestablishment of the normal protective mechanism of the barrier, vision returns. It is not clear whether the disruption is due to the production of hypoxia or microembolism, or to a direct destructive effect of the compound. No radiographic evidence was obtained to implicate temporary spasm or major vessel embolism from the catheter site as the etiological element.
